U.S., May 28 -- ClinicalTrials.gov registry received information related to the study (NCT07609043) titled 'Impact of Prasterone on Cardiometabolic Indicators in Perimenopausal Women.' on April 01, 2023.
Brief Summary: Perimenopause is the natural transition period towards menopause, in which the ovarian reserve begins to decrease, and the woman loses her fertility. It usually starts around the age of 40 and has a variable duration. It has been identified that the decrease in estrogen levels leads to the development of metabolic and cardiovascular complications, such as metabolic syndrome. Dehydroepiandrosterone (DHEA) is a hormone that converts to testosterone and estrogen and is mainly associated with age-related changes in cardiovascula...